Cargando…

Therapeutic anticoagulation in COVID-19 patients

Detalles Bibliográficos
Autores principales:	Belfaqeeh, O., Patel, J., Janapala, R.N., Pourmand, A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier Ltd. 2021
Materias:	Letter to the Editors-in-Chief
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7884252/ https://www.ncbi.nlm.nih.gov/pubmed/33610333 http://dx.doi.org/10.1016/j.thromres.2021.02.006

Ejemplares similares

Azithromycin, a questionable treatment for COVID-19
por: Belfaqeeh, O., et al.
Publicado: (2021)

Novaferon, treatment in COVID-19 patients
por: Janapala, Rajesh Naidu, et al.
Publicado: (2021)

Therapeutic anticoagulation in COVID-19 patients
por: Lemos, Anna Cristina Bertoldi, et al.
Publicado: (2021)

COVID-19: could CT provide the best population level biomarker? Incidental COVID-19 in major trauma patients suggests higher than predicted rates of infection in London
por: Alhashmi, A., et al.
Publicado: (2021)

Organizational characteristics: Effect on outcome of ICU COVID-19 patients in Belgium
por: Patel, Jigar, et al.
Publicado: (2021)

A perfect storm: Root cause analysis of supra-therapeutic anticoagulation with vitamin K antagonists during the COVID-19 pandemic
por: Speed, V., et al.
Publicado: (2020)

Letter to the Editor Regarding Combination of Tocilizumab and Steroids to Improve Mortality in Patients with Severe COVID-19 Infection: A Spanish, Multicenter, Cohort Study
por: Janapala, Rajesh Naidu, et al.
Publicado: (2021)

Intensity of anticoagulation and survival in patients hospitalized with COVID-19 pneumonia
por: Hsu, Andrew, et al.
Publicado: (2020)

When to use anticoagulation in COVID-19()()
por: Moll, Matthew, et al.
Publicado: (2021)

Effect of therapeutic anticoagulation on gas exchange in mechanically ventilated COVID-19 patients: A secondary analysis of the COVID-HEP trial
por: Pantet, Olivier, et al.
Publicado: (2023)

The impact of different prophylactic anticoagulation doses on the outcomes of patients with COVID-19
por: Jiménez-Soto, Rodolfo, et al.
Publicado: (2021)

Heparin failure and COVID-19: Should we explore other anticoagulants? An observational report regarding in-vitro recovery of anticoagulant action in COVID-19 patients in intensive care
por: Thomas, W., et al.
Publicado: (2020)

Anticoagulation therapy in COVID-19: Is there a dose-dependent benefit?
por: Kollias, Anastasios, et al.
Publicado: (2021)

Clinical outcomes of patients with mild COVID-19 following treatment with hydroxychloroquine in an outpatient setting
por: Janapala, Rajesh Naidu, et al.
Publicado: (2021)

Pre-admission anticoagulant therapy and mortality in hospitalized COVID-19 patients: A retrospective cohort study
por: van Haaps, Thijs F., et al.
Publicado: (2021)

Effect of dexamethasone on direct Xa-inhibitor oral anticoagulant plasma levels in patients with COVID-19
por: Bosch, Floris T.M., et al.
Publicado: (2021)

The effect of anticoagulation on clinical outcomes in novel Coronavirus (COVID-19) pneumonia in a U.S. cohort
por: Lynn, Lei, et al.
Publicado: (2021)

Protective effect of oral anticoagulant drugs in atrial fibrillation patients admitted for COVID-19: Results from the CORIST study
por: Ageno, Walter, et al.
Publicado: (2021)

Coagulopathy monitoring and anticoagulation management in COVID-19 patients on ECMO: Advantages of a heparin anti-Xa-based titration strategy
por: Rhoades, Ruben, et al.
Publicado: (2021)

Warfarin anticoagulation in the Covid-19 pandemic: Telephone-based management at a regional hematology outpatient center in Joinville, Brazil
por: Machado, Kendra Lys Calixto, et al.
Publicado: (2021)

Association of anticoagulation use with SARS-CoV2 detection()
por: Kavecansky, Juraj, et al.
Publicado: (2021)

The effect of race on composite thrombotic events in patients with COVID-19
por: Esenwa, Charles, et al.
Publicado: (2021)

Three-month follow-up of pulmonary embolism in patients with COVID-19
por: Whyte, Martin B., et al.
Publicado: (2021)

Asymptomatic deep vein thrombosis in critically ill COVID-19 patients despite therapeutic levels of anti-Xa activity
por: Torres-Machorro, Adriana, et al.
Publicado: (2020)

Portal vein thrombosis in a patient with COVID-19
por: Franco-Moreno, A., et al.
Publicado: (2020)

Thrombotic complications in critically ill patients with COVID 19
por: Rosen, Raphael J.
Publicado: (2020)

Early thromboembolic events in hospitalized COVID-19 patients
por: Rosen, Raphael J.
Publicado: (2020)

Rotational thromboelastometry to assess hypercoagulability in COVID-19 patients
por: van Veenendaal, Nadine, et al.
Publicado: (2020)

“COVID-19 associated divergent thrombotic thrombocytopenic purpura (TTP) syndromes reported so far, five and counting”: Classification and possible therapeutic options
por: Mir, Tajamul H.
Publicado: (2022)

Increased prevalence of heparin induced thrombocytopenia in COVID-19 patients
por: Preti, Paola S., et al.
Publicado: (2021)

Heparin-induced thrombocytopenia and thrombosis in a patient with Covid-19()
por: Huang, Ching-Tai, et al.
Publicado: (2020)

D-dimer cut-off points and risk of venous thromboembolism in adult hospitalized patients with COVID-19
por: Choi, Justin J., et al.
Publicado: (2020)

Thrombotic complications of patients admitted to intensive care with COVID-19 at a teaching hospital in the United Kingdom
por: Thomas, W., et al.
Publicado: (2020)

Thrombosis post COVID-19 vaccinations: Potential link to ACE pathways
por: Dalan, Rinkoo, et al.
Publicado: (2021)

Pulmonary embolism in COVID-19 patients: prevalence, predictors and clinical outcome
por: Scudiero, Fernando, et al.
Publicado: (2021)

Role of upfront CT pulmonary angiography at admission in COVID-19 patients
por: Jalaber, Carole, et al.
Publicado: (2020)

COVID-19 associated coagulopathy: Thrombosis, hemorrhage and mortality rates with an escalated-dose thromboprophylaxis strategy
por: Daughety, Molly M., et al.
Publicado: (2020)

Extensive pulmonary perfusion defects compatible with microthrombosis and thromboembolic disease in severe Covid-19 pneumonia
por: Beenen, L.F.M., et al.
Publicado: (2020)

Impact of blood type on thrombosis and disease severity in adult COVID-19 patients()
por: Rao, Shivani, et al.
Publicado: (2021)

Systemic thromboemboli in patients with Covid-19 may result from paradoxical embolization
por: Rajendram, Rajkumar, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_v39e30berc0kbcj6kv2prp7p5h